Susquehanna International Group, LLP Gossamer Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $14,220 - $22,500	-18,000 Reduced 3.71%	466,900 $462,000
Q2 2024 Aug 15, 2024	BUY	$0.51 - $1.27 $1,326 - $3,302	2,600 Added 0.54%	484,900 $436,000
Q1 2024 May 07, 2024	SELL	$0.8 - $1.51 $128,160 - $241,902	-160,200 Reduced 24.93%	482,300 $569,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $139,248 - $313,308	290,100 Added 82.32%	642,500 $584,000
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $197,106 - $459,914	252,700 Added 253.46%	352,400 $292,000
Q2 2023 Aug 11, 2023	BUY	$0.98 - $1.53 $61,544 - $96,084	62,800 Added 170.19%	99,700 $119,000
Q1 2023 May 16, 2023	SELL	$0.96 - $2.92 $57,312 - $174,324	-59,700 Reduced 61.8%	36,900 $46,000
Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $83,172 - $615,186	-47,800 Reduced 33.1%	96,600 $209,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $915,670 - $1.89 Million	127,000 Added 729.89%	144,400 $1.73 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $69.5M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.